“…Thus, ROS together with activated JNK and inactive Bcl-2 cause severe damage to the cells, resulting in ischemia injury (Donovan, Becker, Konishi, & Bonni, 2002). Several studies have reported the involvement of ROS-JNK and Bcl-2 signaling in disease pathologies (Tian, He, Yang, & Liu, 2017;Zhu et al, 2018), where inhibition of this pathway had positive effects on disease attenuation (Lee, Lee, Ko, Hong, & Lee, 2010). ROS-induced oxidative injury often involves the participation of JNK and other cell death signaling pathways (Chen et al, 2016;Fan et al, 2017).…”